In brief
As mpox infection rates rise in Kinshasa, with two new strains identified, health officials face mounting pressure from the worsening situation compounded by unutilized vaccines, especially within vulnerable populations.
In the heart of Kinshasa, the capital of the Democratic Republic of Congo, health authorities are battling an escalating mpox outbreak that threatens to undermine global health containment efforts. The virus, which is closely related to smallpox, is rapidly spreading through communities, especially those reliant on sex work, with many infected individuals lacking prior knowledge of the disease.Mireille Efonge, a resident of the impoverished Pakadjuma neighborhood, became symptomatic a few months ago, suffering from fever and painful lesions that rendered her immobile. Transported to a local health center, she was later diagnosed with mpox—a name unfamiliar to her at the time. August marked a pivotal moment with the emergence of a fast-spreading strain detected in an eastern mining town, prompting the World Health Organization to classify mpox as a global public health emergency. Researchers now reflect on the time before this designation, recognizing a lost opportunity to limit the virus’s spread. The situation has rapidly deteriorated, particularly in overcrowded camps housing millions of internally displaced persons who contend with insufficient water and sanitation. With Kinshasa's extensive population nearing 17 million, the impact of the virus is exacerbated. Compounding these challenges, a substantial stockpile of vaccines sent to combat the outbreak remains unused, marking a critical gap in the public health response.As experts and health workers grapple with this precarious scenario, the urgency to implement effective disease control measures intensifies. The local and global health communities are called to action as they seek to contain mpox's further penetration in already distressed areas of Congo.
